Acute myeloid leukemia under lenalidomide therapy in a patient with multiple myeloma | Zendy

Ali Eser | Zendy; Funda Pepedil Tanrıkulu | Zendy; Ayşe Tülin Tuğlular | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acute myeloid leukemia under lenalidomide therapy in a patient with multiple myeloma

Author(s) -

Ali Eser,

Funda Pepedil Tanrıkulu,

Ayşe Tülin Tuğlular

Publication year - 2016

Publication title -

medical science and discovery

Language(s) - English

Resource type - Journals

ISSN - 2148-6832

DOI - 10.17546/msd.84603

Subject(s) - medicine , lenalidomide , multiple myeloma , myeloid leukemia , oncology , thalidomide , dermatology

A 53-year-old patient who had a 7 year history of multiple myeloma was diagnosed with high risk myelodysplastic syndrome while on lenalidomide treatment. Progression to acute myeloid leukemia has occurred during the following 4 months. Like our case, secondary primary malignancies (SPMs) can rarely complicate treatment of multiple myeloma. Although possible association between SPMs in patients receiving lenalidomide can be attributed to previous melphalan use, potential SPM risk with lenalidomide cannot still be ruled out safely

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research